Search results for: 'long test care software'

The Malaysian immunochemistry market is dominated by Roche, Siemens, and Beckman Coulter. Other participants are Becton Dickenson, Abbott, Sysmex, and some Chinese companies. The demand for immunochemistry tests in tertiary care hospitals is high. Automated equipment is preferred but some tier I and II hospitals operate on semi-automated chemistry ...

China is entering a decade of macroeconomic transformation, with growth expected to moderate from an average of 5.7% between 2015 and 2025 to 3.7% between 2025 and 2035. This slowdown is being driven by structural factors like population aging, property sector correction, and shifting global trade dynamics. In this scenario, China is accelerating i...

The In-vitro Diagnostics (IVD) market in China shows strong growth potential in several segments. Market growth is set to be driven by the growing volume of tests, rather than the higher price of testing solutions in traditional segments and the popularization of advanced testing technology in emerging segments. In the context of the reform in publ...

This research service analyses the IVD market in Taiwan strategically by evaluating the various forces that are currently influencing this market. It analyzes the revenue potential for the key segments in this market, namely clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular testing, SMBG, and point-of-care testing, a...

Alibaba is leading a new wave in the automotive market in China. It is enhancing its supply chain to a higher and concentrated vertical level, by interconnecting leading automotive original equipment manufacturers (OEMs), small and medium enterprises (SMEs), distributors, retailers, and consumers from offline presence to online involvement. More t...

This research service analyses the IVD in Korea, strategically, by evaluating the various forces that are currently shaping this market. It analyses the revenue potential for the key segments in this market, namely, clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, SMBG and point-of-care testing and fore...

This research service analyses the IVD in China, strategically, by evaluating the various forces that are currently shaping this market. It analyses the revenue potential for the key segments in this market, namely, clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, SMBG and point-of-care testing and fore...

This research service analyzes the IVD market in Australia strategically by evaluating the various forces that are currently influencing this market. It analyzes the revenue potential for the key segments in this market, namely clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, self-monitoring of blood gl...

19 Jun 2017  |  Asia Pacific  |  Market Research

Growth Opportunities in the APAC IVD Market, Forecast to 2021

Digital Pathology and Laboratory Automation are Two Strategic Themes Driving the Growth of the IVD Market

Infographics

×

The study aims to analyze and forecast the Asia Pacific (APAC) in-vitro diagnostics (IVD) market outlook and technology trends for 2016. Research Scope: • Key trends and opportunities in the IVD market, which has been segmented into 8 major divisions: o Immunochemistry o Self-monitoring Blood Glucose (SMBG) Meter o Hematology o Point-of-care T...